The European Medicines Agency (EMA) has issued a positive opinion for a new Wegovy® 7.2 mg dose, advancing its availability in the European Union (EU)In the STEP UP programme, people with obesity taking Wegovy® 7.2 mg lost an average of 20.7% body weight at 72 weeks; one in three people achieved 25% or more weight loss1*The higher dose adds a new option for substantial weight loss while preserving muscle function and maintaining the established cardiovascular health benefits of Wegovy®2 Bagsværd, Denmark, 1 ...